Lv4
520 积分 2024-10-02 加入
Different Dosage Regimens of Rituximab in Primary Membranous Nephropathy Treatment: A Systematic Review
1个月前
已完结
PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study
2个月前
已完结
CD4 + and CD8 + T-lymphocyte number as predictive marker of relapse after rituximab treatment in childhood-onset refractory nephrotic syndrome
2个月前
已完结
Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET
3个月前
已完结
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
4个月前
已完结
Manipulating a host-native microbial strain compensates for low microbial diversity by increasing weight gain in a wild bird population
5个月前
已完结
Therapeutic targets in membranous nephropathy: plasma cells and complement
5个月前
已完结
Complement activation and effector pathways in membranous nephropathy
5个月前
已完结
Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines
5个月前
已完结
皖公网安备34019202002308
